Early Phase 1 N=70 Randomized Single-blind

Evaluation of Adherence to Topical Agents: Applying Communication Technology to Improve Sunscreen Use

Skin Cancer

Bottom Line

View on ClinicalTrials.gov: NCT00535769 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2012

Primary outcome: Primary: Number of Days the Subjects Are Adherent to Using Sunscreen — 12.6; 23.6 days

Study Design & Population

Study type: Interventional
Phase: Early Phase 1
Interventions: Electronic + no text message (Device); Electronic monitor + text messages (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Massachusetts General Hospital
Primary completion: Nov 2007

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Days the Subjects Are Adherent to Using Sunscreen	12.6; 23.6	—
SECONDARY Usefulness of Text Messaging System	8.31	—
SECONDARY Recalled Frequency of Sunscreen Application	2.14; 2.42	—

Summary

The purpose of this study is to determine if using an electronic reminder improves adherence to sunscreen use. The specific study aims are as follows: 1. To determine whether the use of electronic reminder system increases adherence to topical agents. 2. To assess technological feasibility of measuring adherence to topical agents using electronic monitors specially designed for tubes. 3. To assess technological feasibility of providing electronic reminders using cellular phone text-messaging system. 4. To obtain subjects' feedback on the adherence monitoring and reminder system.

Eligibility Criteria

Inclusion Criteria

18 years of age or older at time of consent, may be men or women.
Capable of giving informed consent
Have a cellular phone capable of receiving text messages.
Able to adhere to the study visit schedule and other protocol requirements.

Exclusion Criteria

Non-English speaking individuals

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00535769). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.